Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-01-02 @ 11:41 AM
Study NCT ID:
NCT03278132
Status:
COMPLETED
Last Update Posted:
2019-01-02
First Post:
2017-09-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine
Sponsor:
Sinovac Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09-15
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-07
First Submit QC Date:
None
Study First Post Date:
2017-09-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-28
Last Update Post Date:
2019-01-02
Last Update Post Date Type:
ACTUAL